By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Grunenthal GmbH 

Pascalstraße 6

Aachen    52076  Germany
Phone: 0241-569-1111 Fax: 0241-569-1112



Company News
Depomed (DEPO) Acquires U.S. Rights To Late-Stage, First-In-Class Pain Product From Grunenthal GmbH 11/18/2015 6:32:37 AM
AYOXXA And Grunenthal GmbH Completed Research Collaboration 6/24/2015 9:16:37 AM
BIO2015 EXCLUSIVE: Public/Private Partnerships “Key Way to Bring Innovation,” Says Grunenthal GmbH CSO 6/22/2015 2:41:50 PM
Grunenthal GmbH Boston Children's Hospital and Proteus, S.A. Forge $85 Million+ Neosaxitoxin Pact 6/15/2015 6:50:29 AM
New Book Claims Grunenthal GmbH Knew About Thalidomide Risk Six Months Before Drug Was Pulled 5/26/2015 6:03:55 AM
AcelRx Pharmaceuticals (ACRX), Grunenthal GmbH Strike Deal Worth $250 Million For Pain Treatment Drug 12/16/2013 9:42:18 AM
Grunenthal GmbH Expands Use of BioClinica, Inc.'s Next Generation Trident IWR/IVR for Global Trial 6/21/2013 9:25:23 AM
EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects 6/6/2013 9:46:45 AM
Grunenthal GmbH Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN) 5/22/2013 9:55:09 AM
Grunenthal GmbH Highlights Significant R&D Advances in Pain, Inflammation as well as INTAC® Tamper-Resistant Technology at World's Largest Biotechnology Conference 4/19/2013 7:40:46 AM